Stock Analysis on Net
Stock Analysis on Net
Microsoft Excel LibreOffice Calc

AbbVie Inc. (NYSE:ABBV)

Balance Sheet: Liabilities and Stockholders’ Equity

Beginner level

AbbVie Inc., consolidated balance sheet: liabilities and stockholders’ equity

US$ in millions

Microsoft Excel LibreOffice Calc
Dec 31, 2019 Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015
Short-term borrowings —  3,699  400  377  406 
Current portion of long-term debt and finance lease obligations 3,753  1,609  6,015  25  2,025 
Sales rebates 4,484  3,939  3,069  2,887  2,355 
Dividends payable 1,771  1,607  1,143  1,028  924 
Accounts payable 1,452  1,546  1,474  1,407  1,597 
Salaries, wages and commissions 830  787  763  644  632 
Royalty and license arrangements 324  304  514  434  411 
Other 2,971  3,748  3,263  2,979  2,544 
Accounts payable and accrued liabilities 11,832  11,931  10,226  9,379  8,463 
Current liabilities 15,585  17,239  16,641  9,781  10,894 
Long-term debt and finance lease obligations, excluding current portion 62,975  35,002  30,953  36,440  29,240 
Deferred income taxes 1,130  1,067  2,490  6,890  5,276 
Contingent consideration liabilities 7,201  4,306  4,266  3,941  — 
Income taxes payable 3,453  4,311  4,675  —  — 
Pension and other post-employment benefits 2,949  1,840  2,740  2,085  1,949 
Liabilities for unrecognized tax benefits 2,772  2,726  2,683  1,166  902 
Other 1,222  1,307  1,241  1,160  844 
Other long-term liabilities 17,597  14,490  15,605  8,352  3,695 
Long-term liabilities 81,702  50,559  49,048  51,682  38,211 
Total liabilities 97,287  67,798  65,689  61,463  49,105 
Common stock, $0.01 par value 18  18  18  18  17 
Common stock held in treasury, at cost (24,504) (24,108) (11,923) (10,852) (8,839)
Additional paid-in-capital 15,193  14,756  14,270  13,678  13,080 
Retained earnings 4,717  3,368  5,459  4,378  2,248 
Accumulated other comprehensive loss (3,596) (2,480) (2,727) (2,586) (2,561)
Stockholders’ equity (deficit) (8,172) (8,446) 5,097  4,636  3,945 
Total liabilities and equity (deficit) 89,115  59,352  70,786  66,099  53,050 

Based on: 10-K (filing date: 2020-02-21), 10-K (filing date: 2019-02-27), 10-K (filing date: 2018-02-16), 10-K (filing date: 2017-02-17), 10-K (filing date: 2016-02-19).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. AbbVie Inc.’s current liabilities increased from 2017 to 2018 but then decreased significantly from 2018 to 2019.
Long-term liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. AbbVie Inc.’s long-term liabilities increased from 2017 to 2018 and from 2018 to 2019.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. AbbVie Inc.’s total liabilities increased from 2017 to 2018 and from 2018 to 2019.
Stockholders’ equity (deficit) Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. AbbVie Inc.’s stockholders’ equity (deficit) decreased from 2017 to 2018 but then slightly increased from 2018 to 2019.